Table 4.
Results of multiple linear analysis with ambulatory blood pressure monitoring indices and renal function
| Indices | Β | Standardized β | t | VIF | P |
|---|---|---|---|---|---|
| Proteinuria | |||||
| Constant | 0.342 | 8.401 | <0.001 | ||
| Diabetes mellitus | 0.002 | 0.214 | 2.552 | 1.336 | 0.003 |
| Chronic kidney disease | 0.001 | 0.304 | 4.487 | 1.118 | 0.001 |
| Loop diuretic use | −0.012 | −0.037 | −1.062 | 1.324 | 0.012 |
| Smoking | 0.006 | 0.094 | 0.689 | 1.033 | 0.011 |
| uACR | |||||
| Constant | 0.515 | 3.279 | 0.001 | ||
| 24-h mean SBP | 0.003 | 0.119 | 4.988 | 1.103 | 0.002 |
| 24-h mean PP | 0.003 | 0.320 | 3.751 | 2.319 | 0.027 |
| 24-h SBP PTE% | 0.000 | 0.223 | 9.041 | 1.201 | 0.001 |
| Chronic kidney disease | 0.002 | 0.204 | 7.773 | 1.057 | <0.001 |
| Loop diuretic use | −0.002 | 0.125 | 8.002 | 1.039 | <0.001 |
| Smoking | 0.002 | 0.438 | 9.848 | 1.242 | 0.003 |
| eGFR | |||||
| Constant | 0.356 | 7.788 | <0.001 | ||
| Age | −0.002 | −0.415 | −5.452 | 1.150 | <0.001 |
| 24-h mean SBP | −0.004 | −0.370 | −1.403 | 1.204 | 0.007 |
| 24-h m PP | −0.011 | −0.098 | −1.062 | 2.656 | 0.012 |
| NT-proBNP | −0.004 | −0.210 | −6.557 | 1.222 | <0.001 |
| Blood urea nitrogen | |||||
| Constant | 0.487 | 3.917 | 0.003 | ||
| 24-h mean SBP | 0.002 | 0.150 | 1.433 | 0.002 | |
| 24-h mean PP | 0.001 | 0.137 | 3.321 | 1.123 | 0.008 |
| 24-h DBP weighted SD | −0.025 | −0.098 | −2.177 | 1.101 | 0.007 |
| 24-h SBP PTE% | 0.002 | 0.219 | 1.676 | 3.206 | 0.015 |
| NT-proBNP | 0.004 | 0.386 | 2.210 | 2.554 | 0.001 |
| Loop diuretic use | 0.002 | 0.102 | 4.589 | 1.114 | < 0.001 |
ABPM, ambulatory blood pressure monitoring; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; NT-proBNP, N-terminal fragment pro-B-type natriuretic peptide; PTE, pressure percent time elevation; SBP, systolic blood pressure; uACR, urinary albumin-to-creatinine ratio; VIF, variance inflation factor.